Biopharma News

Jan 17, 2017
The company agreed to pay Forward Pharma $1.25 billion to settle a patent dispute over the formulation of Tecfidera, the company’s leading multiple sclerosis treatment.
Jan 10, 2017
By BioPharm International Editors
The company announced that it has terminated an agreement made with UMN Pharma for the co-development of influenza vaccine programs in Japan.
Jan 09, 2017
By BioPharm International Editors
Takeda will acquire ARIAD Pharmaceuticals for approximately $5.2 billion.
Jan 09, 2017
The companies will combine expertise on T-cell therapies with two or more binding domains to create novel oncology medications.
Jan 06, 2017
A judge ruled that Regeneron’s mAb be removed from the market after Amgen alleged that the marketing of Praluent hurt its reputation as innovator of this class of drugs.
Jan 05, 2017
By BioPharm International Editors
PF-06410293 met primary endpoints during clinical trials and demonstrated similar efficacy to its reference product.
Jan 05, 2017
By BioPharm International Editors
J&J’s Innovation Global announced the company has entered into 15 new collaborations.
Jan 04, 2017
By BioPharm International Editors
Prokarium in the UK and Probiomed in Mexico hope to demonstrate large-scale production of oral vaccines that will reduce cost compared to injections and improve availability.
Dec 20, 2016
By BioPharm International Editors
Portola signed a $50-million loan agreement with BMS and Pfizer to provide additional funding for the development of andexanet alfa.
Dec 16, 2016
By BioPharm International Editors
The companies entered a manufacturing agreement for the future commercial production of Lenti-D and LentiGlobin product candidates.
native1_300x100
lorem ipsum